As we had already demonstrated a significant reduction for claudin 5 levels in the peritoneal vessels of ovarian cancer patients as compared to the controls in a former study [9] we here performed an analysis on the level of gene expression. The gene discussed is CLDN5; the disease is ovarian carcinoma.